+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mitomycin C"

Gynecological Cancer Drugs Market Report 2025 - Product Thumbnail Image

Gynecological Cancer Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bladder Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Bladder Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Bladder Cancer Pipeline Analysis Report - Product Thumbnail Image

Bladder Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Mitomycin C Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Mitomycin C Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 103 Pages
  • Global
From
Bladder Cancer Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Bladder Cancer Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 394 Pages
  • Global
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 345 Pages
  • Global
Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 321 Pages
  • Global
  • 7 Results (Page 1 of 1)
Loading Indicator

Mitomycin C is an antineoplastic drug used in the treatment of various types of cancer. It is a cytotoxic antibiotic derived from Streptomyces caespitosus, and is used in combination with other drugs to treat a variety of cancers, including bladder, breast, ovarian, and stomach cancer. Mitomycin C works by inhibiting DNA synthesis and cell division, thus preventing the growth and spread of cancer cells. It is administered intravenously or topically, and is available in both generic and branded forms. Mitomycin C is a widely used drug in the oncology market, and is often used in combination with other drugs to treat a variety of cancers. It is also used in combination with radiation therapy to treat certain types of cancer. The drug is available in both generic and branded forms, and is approved for use in many countries around the world. Some companies in the Mitomycin C market include Pfizer, Merck, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more